Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07377487 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TheraSphere Japan Pre-Market Study

Name: TheraSphere Japan Pre-Market Study — clinical trial record (NCT07377487)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: INDIGO

StatusRecruiting

PhaseNot applicable

SponsorBoston Scientific Corporation

Started2026-01-22

View on ClinicalTrials.gov ↗

Amendment history

2026-08-18

5 amendments v3-v7

5 re-verifications since 2026-04-23, no change to tracked fields

2026-03-26

Study Status v2

Primary completion pushed: 2027-03-31 → 2027-06-30

Completion pushed: 2027-04-30 → 2027-12-31

2026-02-18

Study Status v1

Re-verified, no change to tracked fields

2026-01-26

Original filing

Boston Scientific Corporation

92 trials monitored

See 9 trials at risk

Liver Cancer

1,505 trials monitored

See 60 trials at risk

To investigate the safety and effectiveness of BSJ019T in Japanese patients with primary or secondary liver who are not candidate for standard treatment.

Trial Details

NCT Number	NCT07377487
Lead Sponsor	Boston Scientific Corporation
Conditions	Liver Neoplasms
Enrollment	51 participants
Start Date	2026-01-22
Primary Completion	2027-06-30 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-09-25